Live Breaking News & Updates on Kempharm inc

Stay informed with the latest breaking news from Kempharm inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Kempharm inc and stay connected to the pulse of your community

Head-To-Head Survey: Zevra Therapeutics (NASDAQ:ZVRA) versus Daré Bioscience (NASDAQ:DARE)

Head-To-Head Survey: Zevra Therapeutics (NASDAQ:ZVRA) versus Daré Bioscience (NASDAQ:DARE)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Florida , United-states , California , San-diego , Kempharm-inc , Zevra-therapeutics-inc , Bioscience-inc , Zevra-therapeutics , Get-free-report , Given-dar , Ligand-activated-therapy

Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio

/PRNewswire/ -- The global central nervous system (cns) stimulant drugs market size is estimated to grow by USD 6486.71 mn from 2023-2027, according to...

Canada , Germany , China , United-states , United-kingdom , America , American , Jesse-maida , Hisamitsu-pharmaceutical-co , Technavio-research , Market-research-overview , Pfizer-inc

Zevra Therapeutics to Report Second Quarter 2023 Results on August 14, 2023

CELEBRATION, Fla., Aug. 02, 2023 -- Zevra Therapeutics, Inc. , a rare disease therapeutics company, has announced that it will host a conference call and live audio webcast on Monday, August 14,...

Nichol-ochsner , Janine-bogris , Zevra-therapeutics-inc , Exchange-commission , Globenewswire-inc , Corporate-communications , Kempharm-inc , Investor-relations , Vice-president , Concerning-forward-looking-statements , Private-securities-litigation-reform-act , Annual-report

ORPHAZYME A/S: Orphazyme Announces Publication of 2022 Financial Results and Annual Report

Company announcement Orphazyme A/SNo. 02/2023 Ole Maaløes Vej 3DK-2200 Copenhagen

Denmark , United-states , Copenhagen , Køavn- , Anders-vadsholt , Company-registration-no , Orphazymeas-orpha-co-orphazyme , Kempharm-inc , Chief-executive-officer , Chief-financial-officer , Niemann-pick , Kempharm-denmark

Orphazyme Announces Publication of 2022 Financial Results and Annual Report

Orphazyme Announces Publication of 2022 Financial Results and Annual Report
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

Copenhagen , Køavn- , Denmark , United-states , Anders-vadsholt , Company-registration-no , Kempharm-inc , Orphazymeas-orpha-co-orphazyme , Chief-executive-officer , Chief-financial-officer , Niemann-pick , Kempharm-denmark

Orphazyme Announces Publication of 2022 Financial Results and Annual Report

Orphazyme Announces Publication of 2022 Financial Results and Annual Report
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Copenhagen , Køavn- , Denmark , United-states , Anders-vadsholt , Orphazymeas-orpha-co-orphazyme , Kempharm-inc , Chief-executive-officer , Chief-financial-officer , Niemann-pick , Nasdaq-copenhagen ,

StockNews.com Initiates Coverage on Zevra Therapeutics (NASDAQ:KMPH)

StockNews.com started coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Zevra Therapeutics Stock Performance Zevra Therapeutics has a 52-week low of $4.00 and a 52-week high of $6.92. The firm has […]

United-states , America , Richardw-pascoe , Securities-exchange-commission , Renaissance-technologies , Kempharm-inc , York-mellon-corp , America-corp , Zevra-therapeutics , Get-rating , Exchange-commission

StockNews.com Begins Coverage on Zevra Therapeutics (NASDAQ:KMPH)

StockNews.com began coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a research report released on Sunday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Zevra Therapeutics Price Performance Zevra Therapeutics has a one year low of $4.00 and a one year high of $6.92. The company has a […]

Richardw-pascoe , Securities-exchange-commission , Kempharm-inc , Pensionmark-financial-group , Kovack-advisors-inc , Zevra-therapeutics , Get-rating , Exchange-commission , Capital-management , Financial-group , Ligand-activated

Zevra Therapeutics Announces Submission of IND for KP1077 in Narcolepsy

Zevra Therapeutics Announces Submission of IND for KP1077 in Narcolepsy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nichol-ochsner , Janine-bogris , Richardw-pascoe , European-medicines-agency , Exchange-commission , Drug-administration , Zevra-therapeutics-inc , Us-drug-enforcement-agency , Company-early-access-program , Kempharm-inc , Wall-street , Investigational-new-drug

Zevra Therapeutics (ZVRA) Announces Submission of IND for KP1077 in Narcolepsy

Zevra Therapeutics (ZVRA) Announces Submission of IND for KP1077 in Narcolepsy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Richardw-pascoe , Kempharm-inc , Zevra-therapeutics-inc , Drug-administration , Wall-street , Investigational-new-drug , Chief-executive-officer , Zevra-therapeutics ,